Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
about
Presenilin-1 regulates the expression of p62 to govern p62-dependent tau degradationCellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disordersStress-activated cap'n'collar transcription factors in aging and human diseaseSmall molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agentsp62 improves AD-like pathology by increasing autophagyOxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease.Hippocampal endosomal, lysosomal, and autophagic dysregulation in mild cognitive impairment: correlation with aβ and tau pathology8-Oxoguanine Affects DNA Backbone Conformation in the EcoRI Recognition Site and Inhibits Its Cleavage by the EnzymeAlzheimer's disease-associated neurotoxic peptide amyloid-β impairs base excision repair in human neuroblastoma cellsDeclining signal dependence of Nrf2-MafS-regulated gene expression correlates with aging phenotypes.Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium.Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex.Mitochondrial ferritin protects the murine myocardium from acute exhaustive exercise injury.Nucleic acid oxidation: an early feature of Alzheimer's disease.Tert-buthylhydroquinone pre-conditioning exerts dual effects in old female rats exposed to 3-nitropropionic acid.Oxidative stress and β-amyloid protein in Alzheimer's disease.Nuclear and mitochondrial DNA oxidation in Alzheimer's disease.Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?Protein homeostasis, aging and Alzheimer's disease.Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegenerationNrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs.P62/SQSTM1 at the interface of aging, autophagy, and disease.A PGAM5-KEAP1-Nrf2 complex is required for stress-induced mitochondrial retrograde trafficking.Modulation of Autophagy as a Therapeutic Target for Alzheimer's Disease.Identification and functional analysis of Joka2, a tobacco member of the family of selective autophagy cargo receptorsA role for sequestosome 1/p62 in mitochondrial dynamics, import and genome integrity.Behavioral effects of SQSTM1/p62 overexpression in mice: support for a mitochondrial role in depression and anxietyNrf2, a guardian of healthspan and gatekeeper of species longevity.The Efficacy and Pharmacological Mechanism of Zn7MT3 to Protect against Alzheimer's Disease.From autophagy to mitophagy: the roles of P62 in neurodegenerative diseases.Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases.Amyloid β-abrogated TrkA ubiquitination in PC12 cells analogous to Alzheimer's disease.Upregulation of Antioxidant Enzymes by ASS234, a Multitarget Directed Propargylamine for Alzheimer's Disease Therapy.
P2860
Q24296704-889553A0-4C9D-4CAA-9DEB-574FA78CBCE8Q28384232-E8841C14-EE51-4194-A5BA-A9B8754460CAQ28384783-F94A4272-43F6-4F61-BF55-128E6E9E8B6CQ28386244-8053EA49-EC2F-477A-BCB0-58180C64B2C2Q33821175-96ADF1C7-57CF-48DD-9AE5-654BC36732CEQ34983918-CF66F73F-596F-4EED-B0BF-48DEF65568F1Q35196299-C5E83077-0CB1-4A94-AA8C-1BB016E16653Q36165221-71C4C137-9950-430C-9245-8D5CFBF42C0BQ36432541-79F8524D-BA97-4D12-A27C-79A6EF1ABB53Q37022197-9430C87E-E256-4F54-974A-09BAF5E94067Q37238575-533267CB-490F-49DF-92A8-442BD4F6664BQ37588487-CD43483B-A47F-4A08-BFD1-0EDC2EA82BE7Q37603320-EEB4D339-9172-44EB-9FB5-EFE316B4B84AQ37626224-5EF7A9E3-3915-459A-A3BF-10C30D64E57EQ37741509-C0783776-290A-4384-8E77-8C85ED4C373AQ37928994-F3CCD732-19AD-4428-89F3-AAD5C78B7ED8Q37965702-93A2EC90-9269-4C95-A851-A416B81037FAQ37985671-8067D173-734A-455F-89E7-B8B14E44D9C9Q37987808-B7BD078D-F097-4EA8-BF30-3D08FB6769EFQ38057758-09942A41-C5E1-43EE-9159-CD6E02844118Q38124678-83F55236-5621-45A1-B980-C6C7A4063E53Q38190037-F3DF886A-4595-4821-AD60-C703CEE27D5DQ38609453-426F1C5A-B581-404D-A27C-22B91084E5A4Q38911931-83B4D310-EC93-4A77-839A-5FFD27F073F5Q39912154-4FCBC7AE-12FF-4152-8007-15F66E28E604Q42024119-D4BE1174-C819-48B6-84D1-608BBBAB3CD8Q42148425-22ECECA6-3E69-4DD3-9792-97457B613848Q45423906-018EE01A-3421-420E-B240-8EEDE9BB125AQ46331404-3DA710E0-DC32-44F0-923F-5648113FC880Q47604057-D9F23EC3-F0CE-441B-80DC-8E9CD15129E2Q48252631-C56CEA3C-CA3C-4706-856D-64952E79F470Q48314087-F2686FA8-DBDB-438B-B3F0-F01330EC4339Q53379447-7C313E74-EB2F-4DE5-A112-9FEADEE9D604
P2860
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@en
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@nl
type
label
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@en
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@nl
prefLabel
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@en
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@nl
P2093
P2860
P1476
Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease.
@en
P2093
Marie W Wooten
Marla Gearing
Michael C Wooten
P2860
P304
P356
10.1016/J.FREERADBIOMED.2008.11.003
P577
2008-11-21T00:00:00Z